Skip to main content
. 2021 Oct 12;7:137. doi: 10.1038/s41523-021-00343-4

Table 2.

HER2 expression distribution according to breast cancer subtype in the HER2-negative primary and recurrent breast cancer cohort.

HER2 expression n (%)
0 Low p
Primary breast cancer n (%)
HR-positive/HER2-negative 177 (52.7) 159 (47.3) 0.060
Triple-negative 51 (64.6) 28 (35.4)
Recurrent breast cancer n (%)
HR-positive/HER2-negative 139 (46.2) 162 (53.8) 0.001
Triple-negative 74 (63.8) 42 (36.2)